Felix Dewald
Overview
Explore the profile of Felix Dewald including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
725
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dewald F, Steger G, Fish I, Torre-Lage I, Hellriegel C, Milz E, et al.
Pediatrics
. 2024 Apr;
153(5).
PMID: 38596855
Background And Objectives: Test-to-stay concepts apply serial testing of children in daycare after exposure to SARS-CoV-2 without use of quarantine. This study aims to assess the safety of a test-to-stay...
2.
Oberste M, Asenova T, Ernst A, Shah-Hosseini K, Schnorch N, Buess M, et al.
BMC Public Health
. 2024 Feb;
24(1):548.
PMID: 38383381
Background: Amidst the COVID-19 pandemic, vaccination has been a crucial strategy for mitigating transmission and disease severity. However, vaccine-effectiveness may be influenced by various factors, including booster vaccination, as well...
3.
Hamdorf M, Imhof T, Bailey-Elkin B, Betz J, Theobald S, Simonis A, et al.
J Mol Cell Biol
. 2023 Oct;
15(10).
PMID: 37891014
The novel coronavirus pandemic, first reported in December 2019, was caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 infection leads to a strong immune response and activation...
4.
Dewald F, Pirkl M, Paluschinski M, Kuhn J, Elsner C, Schulte B, et al.
Nat Commun
. 2023 May;
14(1):2835.
PMID: 37208323
Determining SARS-CoV-2 immunity is critical to assess COVID-19 risk and the need for prevention and mitigation strategies. We measured SARS-CoV-2 Spike/Nucleocapsid seroprevalence and serum neutralizing activity against Wu01, BA.4/5 and...
5.
Raimondi S, Gandini S, Rubio Quintanares G, Abecasis A, Lopalco P, DEcclesiis O, et al.
BMC Infect Dis
. 2023 Feb;
23(1):96.
PMID: 36797690
No abstract available.
6.
Oberste M, Schnorch N, Shah-Hosseini K, Asenova T, Dewald F, Lehmann C, et al.
BMC Public Health
. 2023 Feb;
23(1):260.
PMID: 36747171
Background: The personal, environmental, and behavioral risk factors that play an important role in the spread of SARS-CoV-2 are still largely unclear. At the same time, there is limited evidence...
7.
Raimondi S, Gandini S, Rubio Quintanares G, Abecasis A, Lopalco P, DEcclesiis O, et al.
BMC Infect Dis
. 2023 Jan;
23(1):1.
PMID: 36597074
Background: Contradictory results were reported on the role of school closure/reopening on the overall SARS-CoV-2 transmission rate, as well as on which kind and level of mitigation measures implemented in...
8.
Dewald F, Detmer S, Pirkl M, Hellmich M, Heger E, Herrmann M, et al.
J Infect Dis
. 2022 Jul;
226(10):1721-1725.
PMID: 35906927
To determine viral dynamics in Omicron breakthrough infections, we measured severe acute respiratory syndrome coronavirus 2 RNA in 206 double-vaccinated or boostered individuals. During the first 3 days following the...
9.
Meyer M, Ruebsteck E, Dewald F, Klein F, Lehmann C, Huenseler C, et al.
Viruses
. 2022 Jul;
14(8).
PMID: 35893673
Objective: This work presents data gathered over a period of over two years in patients between the age of 0 and 18 years. The aim is to provide information on...
10.
Oberste M, Pusch L, Roth R, Shah-Hosseini K, Schmitz J, Heger E, et al.
BMC Public Health
. 2022 Jul;
22(1):1379.
PMID: 35854283
Background: Current incidence estimates of SARS-CoV-2 in Germany rely to a large extent on case notifications. However, the large number of mild or asymptomatic infections is likely to result in...